Monte Rosa Therapeutics (GLUE) announced the company will present preclinical data on the potential of MRT-8102 at the American Heart ...
Data will be presented during Poster Session A on Sunday, November 12, 2023 from 9:00-11:00 am PT BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback